ly2157299
Showing 1 - 10 of 10
Rectal Adenocarcinoma Trial in Portland (LY2157299, Capecitabine, Fluorouracil)
Active, not recruiting
- Rectal Adenocarcinoma
- LY2157299
- +3 more
-
Portland, OregonProvidence Cancer Center
Mar 22, 2022
Prostate Cancer Trial in Washington, Chicago, Baltimore (Enzalutamide, LY2157299)
Recruiting
- Prostate Cancer
- Enzalutamide
- LY2157299
-
Washington, District of Columbia
- +3 more
Jun 1, 2022
Hepatocellular Carcinoma Trial in Worldwide (LY2157299, Sorafenib, Placebo)
Completed
- Hepatocellular Carcinoma
- LY2157299
- +2 more
-
Beijing, China
- +15 more
Feb 14, 2022
Carcinoma, Hepatocellular Trial in Worldwide (LY2157299, Sorafenib, Ramucirumab)
Completed
- Carcinoma, Hepatocellular
- LY2157299
- +2 more
-
Fayetteville, Arkansas
- +39 more
Dec 21, 2020
Glioma Trial in Germany, Spain, United States (LY2157299, Radiation, Temozolomide)
Completed
- Glioma
- LY2157299
- +2 more
-
La Jolla, California
- +9 more
Feb 15, 2017
Tumors, Tumor Metastasis Trial in Tokyo (LY2157299)
Completed
- Neoplasms
- Neoplasm Metastasis
- LY2157299
-
Tokyo, JapanFor additional information regarding investigative sites for thi
Jun 30, 2014
Healthy Volunteers Trial in Daytona Beach (LY2157299)
Completed
- Healthy Volunteers
- LY2157299
-
Daytona Beach, FloridaFor additional information regarding investigative sites for thi
Dec 3, 2013